Imaging a common drug in glioblastoma
Part of Cancer clinical trials.
This trial uses a special imaging technique to see how the drug Acetadote (often used for acetaminophen overdose) behaves in glioblastoma tumors. It may help doctors learn more about the tumor and could guide future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a new diagnosis of glioblastoma.
- You have not had any previous treatment like surgery, radiation, or chemotherapy.
- You are 18 years old or older.
- You are generally healthy and able to do normal activities (a score above 70 on a common health scale).
- Your blood and organ function (such as liver, kidney, and counts of red/white cells and platelets) are within a safe range.
- You are willing to use effective birth control if needed, and you are not pregnant or nursing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether testing drugs on your tumor cells in a lab can help find the best treatment for you. It is for people with a specific type of glioblastoma that has not been treated yet.
This Phase 3 trial tests whether delivering a cancer drug directly into brain blood vessels, along with standard radiation and temozolomide, works better than standard treatment alone in newly diagnosed glioblastoma (GBM). The goal is to improve control of the tumor while comparing side effects between the two approaches.
This study uses special PET scans (fluciclovine and FDG) and advanced MRI to create a detailed metabolic profile of glioblastoma. It may help doctors better understand your tumor before surgery.
This trial uses special MRI scans and a contrast agent to look at the immune environment of glioblastoma tumors. It may help doctors learn more about how the tumor responds to treatment.
This Phase 2 study checks whether a substance called B-amyloid can help show glioblastoma (GBM) more clearly on brain imaging. It may help doctors find where the tumor is growing or changing, especially after surgery and during planned additional surgery.
This Phase 1/2 study tests whether “glutamate inhibitor” medications can be safely added for newly diagnosed glioblastoma, and how they affect treatment outcomes. It’s designed for adults who will also receive the standard chemo‑radiation plan with temozolomide.
Hear when a new Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.